secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001437749-24-013436
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics effects 1-for-75 reverse stock split to meet Nasdaq bid price rule
--------------------------------------------------------------------------------

- Reverse split effective April 26, 2024; shares reduced from ~44.7M to ~0.6M.
- Split is to bring Company into compliance with Nasdaq $1.00 minimum bid price.
- No fractional shares; fraction holders get rounded up to next whole share.
- Ticker remains ATXI; new CUSIP 05360L403. VStock Transfer is exchange agent.
- Holders via brokers need no action; physical certificate holders will receive instructions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924013436/0001437749-24-013436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924013436/atxi20240423_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-013436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer